Structure-based design of protein tyrosine phosphatase inhibitors

Handbook of Experimental Pharmacology

Volumn 167, Issue , 2005, Pages 215-262

  Moller N P H ^a   Andersen, H S ^a   Jeppesen, C B ^a   Iversen, L F ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

Bioinformatics; Diabetes mellitus; Enzyme kinetics; Protein tyrosine phosphatase; PTP1B; X ray

Indexed keywords

EID: 34147167606     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/3-540-26670-4_9     Document Type: Article

References (180)

1. Ahmad F, Considine RV, Goldstein BJ (1995) Increased abundance of receptor-Type protein-Tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. J Clin Invest 95:2806-2812
2. Akamatsu M, Roller PP, Chen L, Zhang ZY, Ye B, Burke TR (1997) Potent inhibition of protein-Tyrosine phosphatase by phosphotyrosine-mimic containing cyclic peptides. Bioorg Med Chem 5:157-163
3. Amoui M, Baylink DJ, Tillman JB, Lau K-HW (2003) Expression of a structurally unique osteoclastic protein-Tyrosine phosphatase is driven by an alternative intronic, celltype-specific promoter. J Biol Chem M303933200
4. Andersen HS, Iversen LF, Jeppesen CB, Branner S, Norris K, Møller KB, Møller NPH (2000) 2-(Oxalyl-Amino)-benzoic acid is a general, competitive inhibitor of proteintyrosine phosphatases. J Biol Chem 275:7101-7108
5. Andersen HS, Olsen OH, Iversen LF, Sorensen ALP, Mortensen SB, Christensen MS, Branner S, Hansen TK, Lau JF, Jeppesen L, Moran EJ, Su J, Bakir F, Judge L, Shahbaz M, Collins T, Vo T, Newman MJ, Ripka WC, Møller NPH (2002) Discovery and SAR of a novel selective and orally bioavailable nonpeptide classical competitive inhibitor class of protein-Tyrosine phosphatase 1B. J Med Chem 45:4443-4459
6. Andersen JN, Mortensen OH, Peters GH, Drake PG, Iversen LF, Olsen OH, Jansen PG, Andersen HS, Tonks NK, Møller NPH (2001) Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol Cell Biol 21:7117-7136
7. Asante-Appiah E, Ball K, Bateman K, Skorey K, Friesen R, Desponts C, Payette P, Bayly C, Zamboni R, Scapin G, Ramachandran C, Kennedy BP (2001) The YRD motif is a major determinant of substrate and inhibitor specificity in T-cell protein-Tyrosine phosphatase. J Biol Chem 276:26036-26043
8. Asante-Appiah E, Patel S, Dufresne C, Roy P, Wang QP, Patel V, Friesen RW, Ramachandran C, Becker JW, Leblanc Y, Kennedy BP, Scapin G (2002) The structure of PTP-1B in complex with a peptide inhibitor reveals an alternative binding mode for bisphosphonates. Biochemistry 41:9043-9051
9. Barford D, Flint AJ, Tonks NK (1994) Crystal-structure of human protein-Tyrosine-phosphatase 1B. Science 263:1397-1404
10. Bilwes AM, Den Hertog J, Hunter T, Noel JP (1996) Structural basis for inhibition of receptor protein-Tyrosine phosphatase-Alpha by dimerization. Nature 382:555-559
11. Blanchetot C, Den Hertog J (2000) Antibody-induced dimerization of HARPTPalpha-EGFR chimera suggests a ligand dependent mechanism of regulation for RPTP alpha. FEBS Lett 484:235-240
12. Blanchetot C, Tertoolen LG, Overvoorde J, Den Hertog J (2002a) Intra-And intermolecular interactions between intracellular domains of receptor protein-Tyrosine phosphatases. J Biol Chem 277:47263-47269
13. Blanchetot C, Tertoolen LGJ, Den Hertog J (2002b) Regulation of receptor protein-Tyrosine phosphatase alpha by oxidative stress. EMBO J 21:493-503
14. Blaskovich MA, Kim HO (2002) Recent discovery and development of protein tyrosine phosphatase inhibitors. Expert Opin Ther Patents 12:871-905
15. Bleasdale JE, Ogg D, Palazuk BJ, Jacob CS, Swanson ML, Wang XY, Thompson DP, Conradi RA, Mathews WR, Laborde AL, Stuchly CW, Heijbel A, Bergdahl K, Bannow CA, Smith CW, Svensson C, Liljebris C, Schostarez HJ, May PD, Stevens FC, Larsen SD (2001) Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin action. Biochemistry 40:5642-5654
16. Burke TR Jr, Zhang Z-Y (1998) Protein-Tyrosine phosphatases: Structure, mechanism, and inhibitor discovery. Biopolymers 47:225-241
17. Burke TR, Lee K (2003) Phosphotyrosyl mimetics in the development of signal transduction inhibitors. Acc Chem Res 36:426-433
18. Burke TR, Kole HK, Roller PP (1994) Potent inhibition of insulin-receptor dephosphorylation by a hexamer peptide-containing the phosphotyrosyl mimetic F2Pmp. Biochem Biophys Res Commun 204:129-134
19. Burke TR, Ye B, Akamatsu M, Ford H, Yan XJ, Kole HK, Wolf G, Shoelson SE, Roller PP (1996a) 4-O-[2-(2-fluoromalonyl)]-l-Tyrosine-A phosphotyrosyl mimic for the preparation of signal-Transduction inhibitory peptides. J Med Chem 39:1021-1027
20. Burke TR, Ye B, Yan XJ, Wang SM, Jia ZC, Chen L, Zhang ZY, Barford D (1996b) Smallmolecule interactions with protein-Tyrosine-phosphatase ptp1b and their use in inhibitor design. Biochemistry 35:15989-15996
21. Burke TR Jr, Yao Z-J, Zhao H, Milne GWA, Wu L, Zhang Z-Y, Voigt JH (1998) Enantioselective synthesis of nonphosphorous-containing phosphotyrosyl mimetics and their use in the preparation of tyrosine phosphatase inhibitory peptides. Tetrahedron 54:9981-9994
22. Calera MR, Vallega G, Pilch PF (2000) Dynamics of protein-Tyrosine phosphatases in rat adipocytes. J Biol Chem 275:6308-6312
23. Charbonneau H, Tonks NK (1992) 1002 Protein phosphatases. Annu Rev Cell Biol 8:463-493
24. Chen L, Wu L, Otaka A, Smyth MS, Roller PP, Burke TR, Denhertog J, Zhang ZY (1995) Why is phosphonodifluoromethyl phenylalanine a more potent inhibitory moiety than phosphonomethyl phenylalanine toward protein-Tyrosine phosphatases. Biochem Biophys Res Commun 216:976-984
25. Cheng A, Uetani N, Simoncic PD, Chaubey VP, Lee-Loy A, Mcglade CJ, Kennedy BP, Tremblay ML (2002) Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev Cell 2:497-503
26. Cho HJ, Krishnaraj R, Itoh M, Kitas E, Bannwarth W, Saito H, Walsh CT (1993) Substrate specificities of catalytic fragments of protein-Tyrosine phosphatases (hPTP-b, LAR, and CD45) toward phosphotyrosylpeptide substrates and thiophosphotyrosylated peptides as inhibitors. Protein Sci 2:977-984
27. Clemens JC, Guan K, Bliska JB, Falkow S, Dixon JE (1991) Microbial pathogenesis and tyrosine dephosphorylation: Surprising bedfellows . Mol Microbiol 5:2617-2620
28. Cohen P (2002) Protein kinases-The major drug targets of the twenty-first century? Nat Rev Drug Discov 1:309-315
29. Cong LN, Chen H, Li YH, Lin CH, Sap J, Quon MJ (1999) Overexpression of protein tyrosine phosphatase-Alpha (PTP-Alpha) but not PTP-kappa inhibits translocation of GLUT4 in rat adipose cells. Biochem Biophys Res Commun 255:200-207
30. Czech MP, Lawrence JC, Lynn WS (1974a) Evidence for electron transfer reactions involved in the Cu2+-dependent thiol activation of fat cell glucose utilization. J Biol Chem 249:1001-1006
31. Czech MP, Lawrence JC, Lynn WS (1974b) Evidence for the involvement of sulfhydryl oxidation in the regulation of fat cell hexose transport by insulin. Proc Natl Acad Sci USA 71:4173-4177
32. Czech MP, Lawrence JC, Lynn WS (1974c) Hexose transport in isolated brown fat cells. A model system for investigating insulin action on membrane transport. J Biol Chem 249:5421-5427
33. Denu JM, Dixon JE (1998) Protein tyrosine phosphatases: Mechanisms of catalysis and regulation. Curr Opin Chem Biol 2:633-641
34. Denu JM, Tanner KG (1998) Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: Evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry 37:5633-5642
35. Denu JM, Lohse DL, Vijayalakshmi J, Saper MA, Dixon JE (1996) Visualization of intermediate and transition-state structures in protein-Tyrosine-phosphatase catalysis. Proc Natl Acad Sci USA 93:2493-2498
36. Desmarais S, Jia Z, Ramachandaran C (1998) Inhibition of protein tyrosine phosphatase PTP1B and CD45 by sulfotyrosyl peptides. Arch Biochem Biophys 354:225-231
37. Desmarais S, Friesen RW, Zamboni R, Ramachandaran C (1999) [Difluro(phosphono) methyl]phenyl-containing peptide inhibitors of protein tyrosine phosphatases. Biochem J 337:219-223
38. Domchek SM, Auger KR, Chatterjee S, Burke TRJ, Shoelson SE (1992) Inhibition of SH2 domain-phosphoprotein association by a nonhydrolyzable phosphonopeptide. Biochemistry 31:9865-9870
39. Dubyak GR, Kleinzeller A (1980) The insulin-mimetic effects of vanadate in isolated rat adipocytes. Dissociation from effects of vanadate as a (Na+-K+)ATPase inhibitor. J Biol Chem 255:5306-5312
40. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan C-C, Ramachandaran C, Gresser MJ, Tremblay ML, Kennedy BP (1999) Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283:1544-1548
41. Elson A, Leder P (1995) Identification of a cytoplasmic, phorbol ester-inducible isoform of protein-Tyrosine-phosphatase epsilon. Proc Natl Acad Sci USA 92:12235-12239
42. Erlanson DA, McDowell RS, He MM, Randal M, Simmons RL, Kung J, Waight A, Hansen SK (2003) Discovery of a new phosphotyrosine mimetic for PTP1B using breakaway tethering. J Am Chem Soc 125:5602-5603
43. Fantus IG, Kadota S, Deragon G, Foster B, Posner BI (1989) Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase. Biochemistry 28:8864-8871
44. Fauman EB, Yuvaniyama C, Schubert HL, Stuckey JA, Saper MA (1996) The x-ray crystalstructures of yersinia tyrosine phosphatase with bound tungstate and nitrate-mechanistic implications. J Biol Chem 271:18780-18788
45. Fischer EH, Charbonneau H, Tonks NK (1991) Protein tyrosine phosphatases: A diverse family of intracellular and transmembrane enzymes. Science 253:401-406
46. Flint AJ, Gebbink MFGB, Franza BR, Hill DE, Tonks NK (1993) Multisite phosphorylation of the protein-Tyrosine phosphatase, PTB1B-identification of cell-cycle regulated and phorbol ester stimulated sites of phosphorylation. EMBO J 12:1937-1946
47. Flint AJ, Tiganis T, Barford D, Tonks NK (1997) Development of substrate-Trapping mutants to identify physiological substrates of protein-Tyrosine phosphatases. Proc Natl Acad Sci USA 94:1680-1685
48. Frangione JV, Oda A, Smith M, Salzman EW, Neel BG (1993) Calpain-catalyzed cleavage and subcellular relocation of protein phosphotyrosine phosphatase 1B (PTP-1B) in human platelets. EMBO J 12:4843-4856
49. Fukada T, Tonks NK (2003) Identification of YB-1 as a regulator of PTP1B expression: Implications for regulation of insulin and cytokine signaling. EMBO J 22:479-493
50. Galic S, Klingler-Hoffmann M, Fodero-Tavoletti MT, Puryer MA, Meng TC, Tonks NK, Tiganis T (2003) Regulation of insulin receptor signaling by the protein tyrosine phosphatase TCPTP. Mol Cell Biol 23:2096-2108
51. Gil-Henn H, Volohonsky G, Toledano-Katchalski H, Gandre S, Elson A (2000) Generation of novel cytoplasmic forms of protein tyrosine phosphatase epsilon by proteolytic processing and translational control. Oncogene 19:4375-4384
52. Gil-Henn H, Volohonsky G, Elson A (2001) Regulation of protein-Tyrosine phosphatases alpha and epsilon by calpain-mediated proteolytic cleavage. J Biol Chem 276:31772-31779
53. Glaser F, Pupko T, Paz I, Bell RE, Bechor-Shental D, Martz E, Ben Tal N (2003) ConSurf: Identification of functional regions in proteins by surface-mapping of phylogenetic information. Bioinformatics 19:163-164
54. Glover NR, Tracey AS (2000) The phosphatase domains of LAR, CD45, and PTP1B: Structural correlations with peptide-based inhibitors. Biochem Cell Biol 78:39-50
55. Gross S, Knebel A, Tenev T, Neininger A, Gaestel M, Herrlich P, Bohmer FD (1999) Inactivation of protein-Tyrosine phosphatases as mechanism of UV-induced signal transduction. J Biol Chem 274:26378-26386
56. Groves MR, Yao Z-J, Roller PP, Burke TR, Barford D (1998) Structural basis for inhibition of the protein tyrosine phosphatase 1B by phosphotyrosine peptide mimetics. Biochemistry 37:17773-17783
57. Guan KL, Dixon JE (1990) Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia. Science 249:553-556
58. Guan KL, Dixon JE (1991) Evidence for protein-Tyrosine-phosphatase catalysis proceeding via a cysteine-phosphate intermediate. J Biol Chem 266:17026-17030
59. Hatakeyama M (2003) Helicobacter pylori CagA-A potential bacterial oncoprotein that functionally mimics the mammalian Gab family of adaptor proteins. Microbes Infect 5:143-150
60. Heffetz D, Zick Y (1992) The insulinomimetic agents hydrogen peroxide and vanadate stimulate tyrosine phosphorylation of potential target proteins for the insulin-receptor kinase in intact-cells. Biochem J 288:631-635
61. Heffetz D, Bushkin I, Dror R, Zick Y (1990) The insulinomimetic agents H2O2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. J Biol Chem 265:2896-2902
62. Hermiston ML, Xu Z, Weiss A (2003) CD45: A critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 21:107-137
63. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, Hatakeyama M (2002) SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295:683-686
64. Hoppe E, Berne PF, Stock D, Rasmussen JS, Møller NPH, Ullrich A, Huber R (1994) Expression, purification and crystallization of human phosphotyrosine phosphatase 1B. Eur J Biochem 223:1069-1077
65. Ibarra-Sanchez MD, Simoncic PD, Nestel FR, Duplay P, Lapp WS, Tremblay ML (2000) The T-cell protein tyrosine phosphatase. Semin Immunol 12:379-386
66. Irie-Sasaki J, Sasaki T, Penninger JM (2003) CD45 regulated signaling pathways. Curr Top Med Chem 3:783-796
67. Iversen LF, Andersen HS, Branner S, Mortensen SB, Peters GH, Norris K, Olsen OH, Jeppesen CB, Lundt BF, Ripka W, Møller KB, Møller NPH (2000) Structure-based design of a low molecular weight, nonphosphorus, nonpeptide, and highly selective inhibitor of protein-Tyrosine phosphatase 1B. J Biol Chem 275:10300-10307
68. Iversen LF, Andersen HS, Møller KB, Olsen OH, Peters GH, Branner S, Mortensen SB, Hansen TK, Lau J, Ge Y, Holsworth DD, Newman MJ, Møller NPH (2001) Steric hindrance as basis for structure-based design of selective inhibitors of protein-Tyrosine phosphatases. Biochemistry 40:14812-14820
69. Iversen LF, Møller KB, Pedersen AK, Peters GH, Petersen AS, Andersen HS, Branner S, Mortensen SB, Møller NP (2002) Structure determination of T cell protein tyrosine phosphatase. J Biol Chem 277:19982-19990
70. Jackson DE (2003) The unfolding tale of PECAM-1. FEBS Lett 540:7-14
71. Jia Z, Ye Q, Dinaut AN, Wang Q, Waddleton D, Payette P, Ramachandran C, Kennedy B, Hum G, Taylor SD (2001) Structure of protein tyrosine phosphatase 1B in complex with inhibitors bearing two phosphotyrosine mimetics. J Med Chem 44:4584-4594
72. Jia ZC, Barford D, Flint AJ, Tonks NK (1995) Structural basis for phosphotyrosine peptide recognition by protein-Tyrosine-phosphatase 1b. Science 268:1754-1758
73. Jiang GL, Den Hertog J, Su J, Noel J, Sap J, Hunter T (1999) Dimerization inhibits the activity of receptor-like protein-Tyrosine phosphatase-Alpha. Nature 401:606-610
74. Jiang GQ, Den Hertog J, Hunter T (2000) Receptor-like protein tyrosine phosphatase alpha homodimerizes on the cell surface. Mol Cell Biol 20:5917-5929
75. Johnson TO, Ermolieff J, Jirousek MR (2002) Protein tyrosine phosphatase 1B inhibitors for diabetes. Nat Rev Drug Discov 1:696-709
76. Kadota S, Fantus IG, Deragon G, Guyda HJ, Hersh B, Posner BI (1987) Peroxide(s) of Vanadium: A novel and potent insulin-mimetic agent which activates the insulin receptor kinase. Biochem Biophys Res Commun 14:259-266
77. Kaniga K, Uralil J, Bliska JB, Galan JE (1996) A secreted protein-Tyrosine-phosphatase with modular effector domains in the bacterial pathogen salmonella-Typhimurium. Mol Microbiol 21:633-641
78. Kar S, Wang MF, Wilcox CS, Carr BI (2003) Antitumor and anticarcinogenic actions of Cpd 5: A new class of protein phosphatase inhibitor. Carcinogenesis 24:411-416
79. Kennedy BP (1999) Role of protein tyrosine phosphatase-1B in diabetes and obesity. Biomed Pharmacother 53:466-470
80. Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, Stricker-Krongrad A, Shulman GI, Neel BG, Kahn BB (2000) Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-Tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20:5479-5489
81. Kole HK, Akamatsu M, Ye B, Yan XJ, Barford D, Roller PP, Burke TR (1995a) Protein-Tyrosine-phosphatase inhibition by a peptide-containing the phosphotyrosyl mimetic, L-O-malonyltyrosine. Biochem Biophys Res Commun 209:817-822
82. Kole HK, Smyth MS, Russ PL, Burke TR (1995b) Phosphonate inhibitors of protein-Tyrosine and serine threonine phosphatases. Biochem J 311:1025-1031
83. Kole HK, Garant MJ, Kole S, Bernier M (1996) A peptide-based protein-Tyrosine-phosphatase inhibitor specifically enhances insulin-receptor function in intact cells. J Biol Chem 271:14302-14307
84. Koshio O, Akanuma Y, Kasuga M (1988) Hydrogen peroxide stimulates tyrosine phosphorylation of the insulin receptor and its tyrosine kinase activity in intact cells. Biochem J 250:95-101
85. Kotoris CC, Chen M, Taylor SD (1998) Novel phosphate mimetics for the design of nonpeptidyl inhibitors of protein tyrosine phosphatases. Bioorg Med Chem Lett 8:3275-3280
86. Koul A, Choidas A, Treder M, Tyagi AK, Drlica K, Singh Y, Ullrich A (2000) Cloning and characterization of secretory tyrosine phosphatases of Mycobacterium tuberculosis. J Bacteriol 182:5425-5432
87. Kulas DT, Zhang W-R, Goldstein BJ, Furlanetto RW, Mooney RA (1995) Insulin receptor signaling is augmented by antisense inhibition of the protein tyrosine phosphatase LAR. J Biol Chem 270:2435-2438
88. Larsen SD, Stevens FC, Lindberg TJ, Bodnar PM, O Sullivan TJ, Schostarez HJ, PalazUK BJ, Bleasdale JE (2003) Modification of the N-Terminus of peptidomimetic protein tyrosine phosphatase 1B (PTP1B) inhibitors: Identification of analogues with cellular activity. Bioorg Med Chem Lett 13:971-975
89. Lee K, Burke TR (2003) CD45 protein-Tyrosine phosphatase inhibitor development. Curr Top Med Chem 3:797-807
90. Liotta AS, Kole HK, Fales HM, Roth J, Bernier M (1994) A synthetic tris-sulfotyrosyl dodecapeptide analog of the insulin-receptor 1146-kinase domain inhibits tyrosine dephosphorylation of the insulin-receptor in-situ. J Biol Chem 269:22996-23001
91. Liu G, Szczepankiewicz BG, Pei ZH, Janowick DA, Xin ZL, Hajduk PJ, Abad-Zapatero C, Liang H, Hutchins CW, Fesik SW, Ballaron SJ, Stashko MA, Lubben T, Mika AK, Zinker BA, Trevillyan JM, Jirousek MR (2003a) Discovery and structure-Activity relationship of oxalylarylaminobenzoic acids as inhibitors of protein tyrosine phosphatase 1B. J Med Chem 46:2093-2103
92. Liu G, Xin Z, Pei Z, Hajduk PJ, Abad-Zapatero C, Hutchins CW, Zhao H, Lubben TH, Ballaron SJ, Haasch DL, Kaszubska W, Rondinone CM, Trevillyan JM, Jirousek MR (2003b) Fragment screening and assembly: A highly efficient approach to a selective and cell active protein tyrosine phosphatase 1B inhibitor. J Med Chem 46:4232-4235
93. Liu G, Xin ZL, Liang H, Abad-Zapatero C, Hajduk PJ, Janowick DA, Szczepankiewicz BG, Pei z, Hutchins CW, Ballaron SJ, Stashko MA, Lubben TH, Berg CE, Rondinone CM, Trevillyan JM, Jirousek MR (2003c) Selective protein tyrosine phosphatase 1B inhibitors: Targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligands. J Med Chem 46:3437-3440
94. Lohse DL, Denu JM, Santoro N, Dixon JE (1997) Roles of aspartic acid-181 and serine-222 in intermediate formation and hydrolysis of the mammalian protein-Tyrosinephosphatase PTP1. Biochemistry 36:4568-4575
95. Lund IK, Andersen HS, Iversen LF, Olsen OH, Møller KB, Pedersen AK, Ge Y, Holsworth DD, Newman MJ, Axe FU, and Møller NPH (2004) Structure-based Design of Selective and Potent Inhibitors of Protein-Tyrosine Phosphatase beta. J Biol Chem 279:24226-24235
96. Maehama T, Taylor GS, Dixon JE (2001) PTEN and myotubularin: Novel phosphoinositide phosphatases. Annu Rev Biochem 70:247-279
97. Mahadev K, Wu XD, Zilbering A, Zhu L, Lawrence JTR, Goldstein BJ (2001a) Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J Biol Chem 276:48662-48669
98. Mahadev K, Zilbering A, Zhu L, Goldstein BJ (2001b) Insulin-stimulated hydrogen peroxide reversibly inhibits protein-Tyrosine phosphatase 1B in vivo and enhances the early insulin action cascade. J Biol Chem 276:21938-21942
99. Majeti R, Bilwes AM, Noel JP, Hunter T, Weiss A (1998) Dimerization-induced inhibition of receptor protein-Tyrosine-phosphatase function through an inhibitory wedge. Science 279:88-91
100. Majeti R, Xu Z, Parslow TG, Olson JL, Daikh DI, Killeen N, Weiss A (2000) An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 103:1059-1070
101. Mauro LJ, Dixon JE (1994) Zip codes direct intracellular protein tyrosine phosphatases to the correct cellular address . TIBS 19:151-155
102. May JM, de Haen C (1979) Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal fat cells. J Biol Chem 254:2214-2220
103. McGovern SL, Shoichet BK (2003) Kinase inhibitors: Not just for kinases anymore. J Med Chem 46:1478-1483
104. McGovern SL, Caselli E, Grigorieff N, Shoichet BK (2002) A common mechanism underlying promiscuous inhibitors from virtual and high-Throughput screening. J Med Chem 45:1712-1722
105. Meng TC, Fukada T, Tonks NK (2002) Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9:387-399
106. Milarski KL, Zhu G, Pearl CG, McNamara DJ, Dobrusin EM, MacLean D, Thieme-Sefler A, Zhang Z-Y, Sawyer T, Decker SJ, Dixon JE, Saltiel AR (1993) Sequence specificity in recognition of the epidermal growth factor receptor by protein tyrosine phosphatase 1B. J Biol Chem 268:23634-23639
107. Miller MJ, Bracccolino DS, Cleary DG, Ream JE, Walker MC, Sikorski JA (1994) EPSP synthase inhibitor design IV. New aromatic substrate analogs and symmetrical inhibitors containing novel 3-phosphate mimics. Bioorg Med Chem Lett 4:2605-2608
108. Moeslein FM, Myers MP, Landreth GE (1999) The CLK family kinases, CLK1 and CLK2, phosphorylate and activate the tyrosine phosphatase, PTP-1B. J Biol Chem 274:26697-26704
109. Møller NPH, Møller KB, Lammers R, Kharitonenkov A, Sures I, Ullrich A (1994a) Src kinase associates with a member of a distinct subfamily of protein-Tyrosine phosphatases containing an ezrin-like domain. Proc Natl Acad Sci U S A 91:7477-7481
110. Møller NPH, Møller KB, Ullrich A, Møller NP (1994b) New protein tyrosine phosphatase PTP-S31 is used to develop products for treating or preventing disease associated with abnormal PTP-531, e.g., cancer or diabetes. Max Planck Ges Foerderung Wissenschaften, [WO9421800-A2], pp 9-29
111. Møller NPH, Møller KB, Lammers R, Kharitonenkov A, Hoppe E, Wiberg FC, Sures I, Ullrich A (1995) Selective down-regulation of the insulin receptor signal by proteintyrosine phosphatases alpha and epsilon. J Biol Chem 270:23126-23131
112. Møller NPH, Iversen LF, Andersen HS, McCormack JG (2000) Protein tyrosine phosphatases (PTPs) as drug targets: Inhibitors of PTP-1B for the treatment of diabetes. Curr Opin Drug Discov Devel 3:527-540
113. Mooney RA, LeVea CM (2003) The leukocyte common antigen-related protein LAR: Dandidate PTP for inhibitory targeting. Curr Top Med Chem 3:809-819
114. Murli S, Watson RO, Galan JE (2001) Role of tyrosine kinases and the tyrosine phosphatase SptP in the interaction of Salmonella with host cells. Cell Microbiol 3:795-810
115. Myers MP, Andersen JN, Cheng A, Tremblay ML, Horvath CM, Parisien JP, Salmeen A, Barford D, Tonks NK (2001) TYK2 and JAK2 are substrates of protein-Tyrosine phosphatase 1B. J Biol Chem 276:47771-47774
116. Norris K, Norris F, Kono DH, Vestergaard H, Pedersen O, Theofilopoulos AN, Møller NPH (1997) Expression of protein-Tyrosine phosphatases in the major insulin target tissues. FEBS Lett 415:243-248
117. Pallen CJ (2003) Protein tyrosine phosphatase alpha (PTPalpha): A Src family kinase activator and mediator of multiple biological effects. Curr Top Med Chem 3:821-835
118. Pannifer ADB, Flint AJ, Tonks NK, Barford D (1998) Visualization of the cysteinyl-phosphate intermediate of a protein-Tyrosine phosphatase by X-ray crystallography. J Biol Chem 273:10454-10462
119. Patankar SJ, Jurs PC (2003) Classification of inhibitors of protein tyrosine phosphatase 1B using molecular structure based descriptors. J Chem Inf Comput Sci 43:885-899
120. Pathak MK, Yi TL (2001) Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines. J Immunol 167:3391-3397
121. Pathak MK, Dhawan D, Lindner DJ, Borden EC, Farver C, Yi TL (2002) Pentamidine is an inhibitor of PRL phosphatases with anticancer activity. Mol Cancer Ther 1:1255-1264
122. Peters GH, Iversen LF, Branner S, Andersen HS, Mortensen SB, Olsen OH, Møller KB, Møller NPH (2000) Residue 259 is a key determinant of substrate specificity of protein-Tyrosine phosphatases 1B and a. J Biol Chem 275:18201-18209
123. Pot DA, Dixon JE (1992a) A thousand and two protein tyrosine phosphatases. Biochim Biophys Acta 1136:35-43
124. Pot DA, Dixon JE (1992b) Active site labeling of a receptor-like protein tyrosine phosphatase. J Biol Chem 267:140-143
125. Puius YA, Zhao Y, Sullivan M, Lawrence DS, Almo SC, Zhang Z-Y (1997) Identification of a second aryl phosphate-binding site in protein-Tyrosine phosphatase 1B: A paradigm for inhibitor design. Proc Natl Acad Sci USA 94:13420-13425
126. Ragab A, Bodin S, Viala C, Chap H, Payrastre B, Ragab-Thomas J (2003) The tyrosine phosphatase 1B regulates LAT phosphorylation and platelet aggregation upon Fcgamma RIIa cross-linking. J Biol Chem 278:40923-40932
127. Ramachandran C, Kennedy BP (2003) Protein tyrosine phosphatase 1B: A novel target for type 2 diabetes and obesity. Curr Top Med Chem 3:749-757
128. Ravichandran LV, Chen H, Li YH, Quon MJ (2001) Phosphorylation of PTP1B at Ser(50) by Akt impairs its ability to dephosphorylate the insulin receptor. Mol Endocrinol 15:1768-1780
129. Ripka WC (2000) Protein tyrosine phosphatase inhibition. Annu Rep Med Chem 35:231-250
130. Ruzzene M, Donella DA, Marin O, Perich JW, Ruzza P, Borin G, Calderan A, Pinna LA (1993) Specificity of T-cell protein tyrosine phosphatase toward phosphorylated synthetic peptides. Eur J Biochem 211:289-295
131. Salmeen A, Andersen JN, Myers MP, Tonks NK, Barford D (2000) Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B. Mol Cell 6:1401-1412
132. Salmeen A, Andersen JN, Myers MP, Meng TC, Hinks JA, Tonks NK, Barford D (2003) Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-Amide intermediate. Nature 423:769-773
133. Sarmiento M, Zhao Y, Gordon SJ, Zhang Z-Y (1998) Molecular-basis for substrate-specificity of protein-Tyrosine-phosphatase 1B. J Biol Chem 273:26368-26374
134. Sarmiento M, Puius YA, Vetter SW, Keng YF, Wu L, Zhang Z-Y (2000) Structural basis of plasticity in protein tyrosine phosphatase 1B substrate recognition. Biochemistry 39:8171-8179
135. Scapin G, Patel S, Patel V, Kennedy B, Asante-Appiah E (2001) The structure of apo protein-Tyrosine phosphatase 1B C215S mutant: More than just an S!O change. Protein Sci 10:1596-1605
136. Schubert HL, Fauman EB, Stuckey JA, Dixon JE, Saper MA (1995) A ligand-induced conformational change in the yersinia protein-Tyrosine- phosphatase. Protein Sci 4:1904-1913
137. Shen K, Keng YF, Wu L, Guo XL, Lawrence DS, Zhang ZY (2001) Acquisition of a specific and potent PTP1B inhibitor from a novel combinatorial library and screening procedure. J Biol Chem 276:47311-47319
138. Shifrin VI, Neel BG (1993) Growth factor-inducible alternative splicing of nontransmembrane phosphotyrosine phosphatase PTP-1B premessenger rna. J Biol Chem 268:25376-25384
139. Skorey K, Ly HD, Kelly J, Hammond M, Ramachandran C, Huang Z, Gresser MJ, Wang QP (1997) How does alendronate inhibit protein-Tyrosine phosphatases. J Biol Chem 272:22472-22480
140. Skorey KI, Kennedy BP, Friesen RW, Ramachandran C (2001) Development of a robust scintillation proximity assay for protein tyrosine phosphatase 1B using the catalytically inactive (C215S) mutant. Anal Biochem 291:269-278
141. Smyth MS, Ford H, Jr, Burke TR Jr. (1992) A general-method for the preparation of benzylic alpha, alpha-difluorophosphonic acids-nonhydrolyzable mimetics of phosphotyrosine. Tetrahedron Lett 33:4137-4140
142. Stuckey JA, Schubert HL, Fauman EB, Zhang ZY, Dixon JE, Saper MA (1994) Crystalstructure of yersinia protein-Tyrosine-phosphatase at 2. 5-Angstrom and the complex with tungstate. Nature 370:571-575
143. Sun JP, Fedorov AA, Lee SY, Guo XL, Shen K, Lawrence DS, Almo SC, Zhang ZY (2003) Crystal structure of PTP1B complexed with a potent and selective bidentate inhibitor. J Biol Chem 278:12406-12414
144. Szczepankiewicz BG, Liu G, Hajduk PJ, Abad-Zapatero C, Pei ZH, Xin ZL, Lubben TH, Trevillyan JM, Stashko MA, Ballaron SJ, Liang H, Huang F, Hutchins CW, Fesik SW, Jirousek MR (2003) Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy. J Am Chem Soc 125:4087-4096
145. Taing M, Keng YF, Shen K, Wu L, Lawrence DS, Zhang ZY (1999) Potent and highly selective inhibitors of the protein tyrosine phosphatase 1B. Biochemistry 38:3793-3803
146. Tamura S, Brown TA, Whipple JH, Fujita-Yamaguchi Y, Dubler RE, Cheng K, Larner J (1984) A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes. J Biol Chem 259:6650-6658
147. Tanuma N, Nakamura K, Kikuchi K (1999) Distinct promoters control transmembrane and cytosolic protein tyrosine phosphatase epsilon expression during macrophage differentiation. Eur J Biochem 259:46-54
148. Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A, Hahlen K, Hasle H, Licht JD, Gelb BD (2003) Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 34:148-150
149. Taylor SD, Kotoris CC, Dinaut AN, Wang QP, Ramachandran C, Huang Z (1998) Potent non-peptidyl inhibitors of protein-Tyrosine-phosphatase 1b. Bioorg Med Chem 6:1457-1468
150. Tonks NK (2003) PTP1B: From the sidelines to the front lines! FEBS Lett 546:140-148
151. Tonks NK, Neel BG (2001) Combinatorial control of the specificity of protein tyrosine phosphatases. Curr Opin Cell Biol 13:182-195
152. Tonks NK, Diltz CD, Fischer EH (1988a) Characterization of the major protein-Tyrosinephosphatases of human placenta. J Biol Chem 263:6731-6737
153. Tonks NK, Diltz CD, Fischer EH (1988b) Purification of the major protein-Tyrosine-phosphatases of human placenta. J Biol Chem 263:6722-6730
154. Urbanek RA, Suchard SJ, Steelman GB, Knappenberger KS, Sygowski LA, Veale CA, Chapdelaine MJ (2001) Potent reversible inhibitors of the protein tyrosine phosphatase CD45. J Med Chem 44:1777-1793
155. Van Der Wijk T, Blanchetot C, Overvoorde J, Den Hertog J (2003) Redox-regulated rotational coupling of receptor protein-Tyrosine phosphatase alpha dimers. J Biol Chem 278:13968-13974
156. van Huijsduijnen RH, Bombrun A, Swinnen D (2002) Selecting protein tyrosine phosphatases as drug targets. Drug Discov Today 7:1013-1019
157. van Montfort RLM, Congreve M, Tisi D, Carr R, Jhoti H (2003) Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B. Nature 423:773-777
158. Vetter SW, Keng YF, Lawrence DS, Zhang ZY (2000) Assessment of protein-Tyrosine phosphatase 1B substrate specificity using inverse alanine scanning. J Biol Chem 275:2265-2268
159. Walchli S, Curchod ML, Gobert RP, Arkinstall S, van Huijsduijnen RH (2000) Identification of tyrosine phosphatases that dephosphorylate the insulin receptor-A brute force approach based on substrate-Trapping mutants. J Biol Chem 275:9792-9796
160. Wang QP, Huang Z, Ramachandran C, Dinaut AN, Taylor SD (1998) Naphthalenebis[alpha, alpha-difluoromethylenephosphonates] as potent inhibitors of protein-Tyrosine phosphatases. Bioorg Med Chem Lett 8:345-350
161. Wang XY, Bergdahl K, Heijbel A, Liljebris C, Bleasdale JE (2001) Analysis of in vitro interactions of protein tyrosine phosphatase 1B with insulin receptors. Mol Cell Endocrinol 173:109-120
162. Wishart MJ, Dixon JE (2002) PTEN and myotubularin phosphatases: From 3-phosphoinositide dephosphorylation to disease. Trends Cell Biol 12:579-585
163. Wrobel J, Sredy J, Moxham C, Dietrich A, Li ZN, Sawicki DR, Seestaller L, Wu L, Katz A, SulliVan D, Tio C, Zhang ZY (1999) PTP1B inhibition and antihyperglycemic activity in the ob/ob mouse model of novel 11-Arylbenzo[b] naphtho[2,3-d]furans and 11-Arylbenzo[b] naphtho [2,3-d] thiophenes. J Med Chem 42:3199-3202
164. Wu C, Sun M, Liu L, Zhou GW (2003) The function of the protein tyrosine phosphatase SHP-1 in cancer. Gene 306:1-12
165. Xie LP, Zhang YL, Zhang ZY (2002) Design and characterization of an improved protein tyrosine phosphatase substrate-Trapping mutant. Biochemistry 41:4032-4039
166. Xin ZL, Oost TK, Abad-Zapatero C, Hajduk PJ, Pei ZH, Szczepankiewicz BG, Hutchins CW, Ballaron SJ, Stashko MA, Lubben T, Trevillyan JM, Jirousek MR, Liu G (2003) Potent, selective inhibitors of protein tyrosine phosphatase 1B. Bioorg Med Chem Lett 13:1887-1890
167. Yahiro K, Niidome T, Kimura M, Hatakeyama T, Aoyagi H, Kurazono H, Imagawa K, Wada A, Moss J, Hirayama T (1999) Activation of Helicobacter pylori VacA toxin by alkaline or acid conditions increases its binding to a 250-kDa receptor protein-Tyrosine phosphatase beta. J Biol Chem 274:36693-36699
168. Yahiro K, Wada A, Nakayama M, Kimura T, Ogushi K, Niidome T, Aoyagi H, Yoshino K, Yonezawa K, Moss J, Hirayama T (2003) Protein-Tyrosine phosphatase alpha, RPTP alpha, is a Helicobacter pylori VacA receptor. J Biol Chem 278:19183-19189
169. Yang J, Cheng ZL, Niu TQ, Liang XS, Zhao ZZJ, Zhou GW (2000) Structural basis for substrate specificity of protein-Tyrosine phosphatase SHP-1. J Biol Chem 275:4066-4071
170. Ye B, Burke TR (1995) L-O-(2-malonyl)tyrosine (L-OMT) a new phosphotyrosyl mimic suitably protected for solid-phase synthesis of signal-Transduction inhibitory peptides. Tetrahedron Lett 36:4733-4736
171. Ye B, Burke TR (1996) Synthesis of a difluorophosphonomethyl-containing phosphatase inhibitor designed from the X-ray structure of a ptp1b-bound ligand. Tetrahedron 52:9963-9970
172. Ye B, Akamatsu M, Shoelson SE, Wolf G, Giorgetti-Peraldi S, Yan X, Roller PP, Burke TR Jr. (1995) L-O-(2-Malonyl)tyrosine: A new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides. J Med Chem 38:4270-4275
173. Yi TL, Pathak MK, Lindner DJ, Ketterer ME, Farver C, Borden EC (2002) Anticancer activity of sodium stibogluconate in synergy with IFNs. J Immunol 169:5978-5985
174. Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, Haj F, Wang Y, Minokoshi Y, Kim YB, Elmquist JK, Tartaglia LA, Kahn BB, Neel BG (2002) PTP1B regulates leptin signal transduction in vivo. Dev Cell 2:489-495
175. Zhang ZY, Lee SY (2003) PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity. Expert Opin Investig Drugs 12:223-233
176. Zhang YL, Yao ZJ, Sarmiento M, Wu L, Burke TR, Zhang ZY (2000) Thermodynamic study of ligand binding to protein-Tyrosine phosphatase 1B and its substrate-Trapping mutants. J Biol Chem 275:34205-34212
177. Zhang Z-Y, MacLean D, McNamara DJ, Sawyer TK, Dixon JE (1994a) Protein tyrosine phosphatase specificity: Size and phosphotyrosine positioning requirements in peptide substrates. Biochemistry 33:2285-2290
178. Zhang Z-Y, Thieme-Sefler AM, MacLean D, McNamara DJ, Dobrusin EM, Sawyer TK, Dixon JE (1993) Substrate specificity of the protein tyrosine phosphatases. Proc Natl Acad Sci USA 90:4446-4450
179. Zhang Z-Y, Wang YA, Dixon JE (1994b) Dissecting the catalytic mechanism of protein-Tyrosine phosphatases. Proc Natl Acad Sci USA 91:1624-1627
180. Zinker BA, Rondinone CM, Trevillyan JM, Gum RJ, Clampit JE, Waring JF, Xie N, Wilcox D, Jacobson P, Frost L, Kroeger PE, Reilly RM, Koterski S, Opgenorth TJ, Ulrich RG, Crosby S, Butler M, Murray SF, McKay RA, Bhanot S, Monia BP, Jirousek MR (2002) PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc Natl Acad Sci USA 99:11357-11362.